SHARON REID: Open Payments
NPI 1720618580 · EAST WINDSOR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 61 payments from 10 companies in 2025. Trend: 2023 $567 · 2024 $1,213 · 2025 $1,383
Food & beverage: $1,260Education: $124
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $290 |
| E.R. Squibb & Sons, L.L.C. | 9 | $218 |
| Axsome Therapeutics, Inc. | 6 | $197 |
| ABBVIE INC. | 12 | $185 |
| Teva Pharmaceuticals USA, Inc. | 5 | $174 |
| Janssen Pharmaceuticals, Inc | 5 | $92 |
| Neurocrine BioSciences, Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Vanda Pharmaceuticals Inc. | 4 | $62 |
| Alkermes, Inc. | 2 | $31 |
Products named: CAPLYTA, COBENFY, Auvelity, VRAYLAR, INVEGA SUSTENNA, INGREZZA, FANAPT, REXULTI.
Industry payments across NJ — which companies pay providers there.
